List of insiders holdings for Stablecoin Development Corp:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | R01 Fund LP Kazley Michael John R01 Capital LLC R01 Capital Manager LLC 10% Owner | 2026-05-19 21:02:57 | 37,548,058 0 | 37,548,058 | Form 13D |
| 2 | Framework Ventures IV L.P. Framework Ventures Management LLC Framework Ventures IV GP LLC Spencer Vance Anderson Michael Ernest 10% Owner | 2026-05-19 21:04:11 | 32,715,086 0 | 32,715,086 | Form 13D |
| 3 | Lazar David E. 10% Owner | 2026-01-29 19:38:30 | 6,388,000 0 | 6,388,000 | Form 13D |
| 4 | China Pioneer Pharma Holdings Ltd 10% Owner | 2017-01-13 15:03:52 | 5,212,748 0 | 5,212,748 | Form 13D |
| 5 | Pioneer Pharma (Hong Kong) Co Ltd 10% Owner | 2019-06-13 21:32:01 | 5,188,421 0 | 5,188,421 | Form 4 |
| 6 | Pioneer Pharma (Singapore) Pte. Ltd. 10% Owner | 2016-09-26 18:05:14 | 5,188,421 0 | 5,188,421 | Form 4 |
| 7 | Najafi Ramin Najafi Family Trust dated September 13 2006 Chief Executive Officer | 2015-02-11 14:03:12 | 4,198,656 0 | 4,198,656 | Form 13G |
| 8 | NAQU AREA PIONEER PHARMA CO. LTD. 10% Owner | 2012-11-20 14:14:24 | 0 4,000,000 | 4,000,000 | Form 4 |
| 9 | Fu Jian Ping 10% Owner | 2020-08-24 17:04:46 | 4,000,000 0 | 4,000,000 | Form 13D |
| 10 | POPLAR POINT CAPITAL PARTNERS LP POPLAR POINT CAPITAL MANAGEMENT LLC POPLAR POINT CAPITAL GP LLC FAKHRY JAD 10% Owner | 2026-03-11 13:27:52 | 1,020,300 0 | 1,020,300 | Form 13D |
| 11 | WU ROY J SVP Bus & Corp Development | 2015-10-06 20:17:19 | 639,725 0 | 639,725 | Form 4 |
| 12 | Khosrovi Behzad SVP Product Development | 2013-01-14 20:46:03 | 536,283 0 | 536,283 | Form 4 |
| 13 | Dailley Anthony Director | 2014-03-21 19:24:58 | 477,226 0 | 477,226 | Form 4 |
| 14 | Stroman David W. SVP, Ophthalmic Product Devt. | 2015-10-06 20:23:35 | 474,834 0 | 474,834 | Form 4 |
| 15 | McGovern John Joseph Int Pres, CEO, CFO & Treasurer | 2018-10-11 16:30:29 | 440,000 0 | 440,000 | Form 4 |
| 16 | Cashion Charles Director | 2015-01-06 18:02:56 | 377,156 0 | 377,156 | Form 4 |
| 17 | PAULSON THOMAS J CFO | 2017-01-26 18:43:17 | 310,788 0 | 310,788 | Form 4 |
| 18 | Wicks Tony D.S. Director | 2015-01-06 16:31:06 | 301,016 0 | 301,016 | Form 4 |
| 19 | Law Tommy Chief Financial Officer | 2026-04-08 16:54:11 | 300,000 0 | 300,000 | Form 4 |
| 20 | Bley Keith R SVP Product Development | 2014-09-30 14:18:34 | 258,120 0 | 258,120 | Form 4 |
| 21 | Anderson Mark Brian CSO | 2011-11-01 18:32:23 | 242,000 0 | 242,000 | Form 4 |
| 22 | Tufts Robert R. Director | 2014-01-31 19:48:02 | 191,468 0 | 191,468 | Form 4 |
| 23 | Freiman Paul E. Director | 2026-04-21 16:51:54 | 140,000 0 | 140,000 | Form 4 |
| 24 | Zheng Yenyou Director | 2026-04-09 16:50:36 | 140,000 0 | 140,000 | Form 4 |
| 25 | Sit Swan Director | 2026-04-02 16:54:10 | 140,000 0 | 140,000 | Form 4 |
| 26 | O'Reilly John James SVP Business and Corporate Dev | 2011-02-01 18:31:29 | 94,400 0 | 94,400 | Form 4/A |
| 27 | HIXSON HARRY F JR Director | 2010-01-05 16:25:34 | 88,316 0 | 88,316 | Form 4 |
| 28 | Hall Justin CEO, GC and Director | 2022-09-16 20:45:30 | 83,172 0 | 83,172 | Form 4 |
| 29 | Xu Wang NEO - Sr Mgr and Controller | 2020-08-24 16:49:57 | 75,000 0 | 75,000 | Form 4 |
| 30 | Scott Colin VP, Clinical Research and Dev | 2011-02-01 18:18:25 | 72,900 0 | 72,900 | Form 4/A |
| 31 | McPherson T. Alex Director | 2016-01-06 18:43:04 | 44,210 0 | 44,210 | Form 4 |
| 32 | Ma Yonghao Director | 2018-06-04 14:24:11 | 43,629 0 | 43,629 | Form 4 |
| 33 | Hoon Russell A. Senior Vice President | 2015-04-30 15:01:30 | 34,217 0 | 34,217 | Form 4/A |
| 34 | Li Xinzhou Director 10% Owner | 2021-05-25 16:46:20 | 30,000 0 | 30,000 | Form 4 |
| 35 | Garlikov Julie Director | 2024-05-30 21:31:33 | 30,000 0 | 30,000 | Form 4 |
| 36 | WU MIJIA Director | 2024-05-30 21:24:28 | 30,000 0 | 30,000 | Form 4 |
| 37 | Zheng Yongxiang Director | 2024-05-30 21:17:52 | 30,000 0 | 30,000 | Form 4 |
| 38 | Zavodnick Todd Erik Director | 2019-10-30 16:31:06 | 20,000 0 | 20,000 | Form 4 |
| 39 | Maderis Gail J Director | 2019-10-28 16:25:58 | 20,000 0 | 20,000 | Form 4 |
| 40 | SIECZKAREK MARK M Director | 2019-10-28 16:25:22 | 20,000 0 | 20,000 | Form 4 |
| 41 | Liu Yanbin Director | 2018-06-04 14:16:37 | 20,000 0 | 20,000 | Form 4 |
| 42 | LIU XIAOYAN Director | 2017-01-04 18:25:48 | 15,245 0 | 15,245 | Form 4 |
| 43 | Najafi Ramin Chief Executive Officer 10% Owner | 2015-08-21 16:03:12 | 0 12,000 | 12,000 | Form 4 |
| 44 | STUART LEWIS J Chief Commercial Officer | 2018-01-08 18:29:17 | 10,000 0 | 10,000 | Form 4 |
| 45 | Radaelli Massimo Director | 2016-01-06 19:04:33 | 2,400 0 | 2,400 | Form 4 |
| 46 | Kunin Audrey Chief Product Officer | 2022-12-07 16:55:37 | 0 0 | 0 | Form 4 |
| 47 | Jones Andrew D. CFO | 2023-02-17 17:30:55 | 0 0 | 0 | Form 4 |
| 48 | Kunin Jeffrey President, DERMAdoctor, LLC | 2022-12-07 16:55:13 | 0 0 | 0 | Form 4 |
| 49 | Wang Xiaopei Former Director Director | 2020-08-24 16:47:50 | 0 0 | 0 | Form 4 |
| 50 | Raleigh Jason Philip Interim CFO and Treasurer | 2019-10-28 16:30:15 | 0 0 | 0 | Form 4/A |